The use of tocilizumab for the management of COVID-19 emerged since it modulates inflammatory markers by blocking interleukin 6 receptors. Concerns regarding higher thrombosis risk while using ...

In this study, the critical role of the epipharynx in managing long-term coronavirus disease 2019 (COVID-19), and in particular, how residual SARS-CoV-2 RNA affects signalling pathways in the ...

Shares of microcap biotech Invivyd (IVVD) moved higher in the premarket on Tuesday after the Waltham, Massachusetts-headquartered company announced the FDA’s Fast Track designation for its ...

High-titre convalescent plasma therapy given within a week of symptom onset reduced hospitalisation and death and was well tolerated in immunocompromised patients with mild COVID-19. This randomised ...

A study finds that IN-006, a reformulated monoclonal antibody, is safe, well-tolerated, and delivers high antibody levels in the airway—offering a faster and more effective way to fight COVID-19.

Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries ...

WASHINGTON (NewsNation Now) — The U.S. Government has approved an Emergency Use Authorization for an investigational monoclonal antibody therapy “for the treatment of mild-to-moderate COVID-19 in ...

A new study suggests that post-COVID-19 condition (PCC), commonly known as long COVID, has placed a substantial burden on ...